Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Immunotherapy including CAR-T Therapy

Session: BiTE The Dust: T Cell-Engaging Antibody Therapies to Eliminate Autoreactive Immune Compartments in Rheumatic Diseases

Allogeneic CARs and T-Cell Engagers in SLE

Monday, October 27, 2025
9:00 AM – 9:30 AM Central Time

    Speaker(s)

  • AA

    Anca Askanase, MD, MPH

    Director
    Columbia University Medical Center
    New York, New York, United States

    Disclosure(s): Alumis: Advisor or Review Panel Member (Ongoing); Amgen: Advisor or Review Panel Member (Terminated, August 15, 2024); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); NKARTA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Sanofi: Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing)